Skip to main content
Premium Trial:

Request an Annual Quote

What's There To Be Afraid Of?

With cheap sequencing on the horizon, the genetics of genealogy will be in the hands of the consumers that acquire the information, writes blogger Blaine Bettinger at The Genetic Genealogist. Whether they will know what to do with this information is another issue, which begs the question, should people be encouraged to have their genomes sequenced without further studies that actually link this with phenotypic information? Bettinger believes that education is the key to making full genome sequencing useful to consumers, who might otherwise be afraid to have it done.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.